| Ident. | Authors (with country if any) | Title |
|---|
| 000095 (2010) |
Shen-Yang Lim ; Anthony E. Lang | The nonmotor symptoms of Parkinson's disease—An overview |
| 000247 (2009) |
Christine Klein ; Susanne A. Schneider ; Anthony E. Lang | Hereditary parkinsonism: Parkinson disease look‐alikes—An algorithm for clinicians to “PARK” genes and beyond |
| 000254 (2011) |
Christine Klein ; Rosalind Chuang ; Connie Marras ; Anthony E. Lang | The curious case of phenocopies in families with genetic Parkinson's disease |
| 000265 (2009) |
Connie Marras ; Anthony E. Lang ; Shirley W. Eberly ; David Oakes ; Stanley Fahn ; Steven R. Schwid ; Christopher Hyson ; Ira Shoulson | A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohorts |
| 000275 (2011) |
Connie Marras ; Michael P. Mcdermott ; Ken Marek ; Paula Rochon ; Gary Naglie ; Caroline M. Tanner ; Alice Rudolph ; Ira Shoulson ; Anthony E. Lang | Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts |
| 000281 (2011) |
Anthony E. Lang | A critical appraisal of the premotor symptoms of Parkinson's disease: Potential usefulness in early diagnosis and design of neuroprotective trials |
| 000306 (2010) |
Steven R. Schwid ; Janice Bausch ; David Oakes ; Lynn Schuchter ; Caroline Tanner ; Misser Forrest ; Anthony E. Lang ; Ira Shoulson | Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease |
| 000324 (2010) |
Fabrizio Stocchi ; Olivier Rascol ; Karl Kieburtz ; Werner Poewe ; Joseph Jankovic ; Eduardo Tolosa ; Paulo Barone ; Anthony E. Lang ; C. Warren Olanow | Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE‐PD study |
| 000478 (2010) |
Juliana Bronzova ; Cristina Sampaio ; Robert A. Hauser ; Anthony E. Lang ; Olivier Rascol ; Ad Theeuwes ; Serge V. Van De Witte ; Guus Van Scharrenburg | Double‐blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease |
| 000499 (2006) |
Wendy R. Galpern ; Anthony E. Lang | Interface between tauopathies and synucleinopathies: A tale of two proteins |
| 000552 (1992) |
Scott G. Adams ; Anthony E. Lang | Can the Lombard effect be used to improve low voice intensity in Parkinson's disease? |
| 000564 (2006) |
Galit Kleiner-Fisman ; Jan Herzog ; David N. Fisman ; Filippo Tamma ; Kelly E. Lyons ; Rajesh Pahwa ; Anthony E. Lang ; Günther Deuschl | Subthalamic nucleus deep brain stimulation: Summary and meta‐analysis of outcomes |
| 000570 (2011) |
Valerie Voon ; Mandy Sohr ; Anthony E. Lang ; Marc N. Potenza ; Andrew D. Siderowf ; Jacqueline Whetteckey ; Daniel Weintraub ; Glen R. Wunderlich ; Mark Stacy | Impulse control disorders in parkinson disease: A multicenter case–control study |
| 000628 (2009) |
Bernard Ravina ; Caroline Tanner ; Diane Dieuliis ; Shirley Eberly ; Emily Flagg ; Wendy R. Galpern ; Stanley Fahn ; Christopher G. Goetz ; Stephen Grate ; Roger Kurlan ; Anthony E. Lang ; Kenneth Marek ; Karl Kieburtz ; David Oakes ; Robin Elliott ; Ira Shoulson | A longitudinal program for biomarker development in Parkinson's disease: A feasibility study |
| 000632 (2008) |
Valerie Voon ; Paul Krack ; Anthony E. Lang ; Andres M. Lozano ; Kathy Dujardin ; Michael Schüpbach ; James D Mbrosia ; Stephane Thobois ; Filippo Tamma ; Jan Herzog ; Johannes D. Speelman ; Johan Samanta ; Cynthia Kubu ; Helene Rossignol ; Yu-Yan Poon ; Jean A. Saint-Cyr ; Claire Ardouin ; Elena Moro | A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease |
| 000744 (2007) |
Robert A. Hauser ; Olivier Rascol ; Amos D. Korczyn ; A. Jon Stoessl ; Ray L. Watts ; Werner Poewe ; Peter P. De Deyn ; Anthony E. Lang | Ten‐year follow‐up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa |
| 000902 (2003) |
Taresa Stefurak ; David Mikulis ; Helen Mayberg ; Anthony E. Lang ; Stephanie Hevenor ; Peter Pahapill ; Jean Saint-Cyr ; Andres Lozano | Deep brain stimulation for Parkinson's disease dissociates mood and motor circuits: A functional MRI case study |
| 000A20 (2006) |
Anthony E. Lang ; Jean-Luc Houeto ; Paul Krack ; Cynthia Kubu ; Kelly E. Lyons ; Elena Moro ; William Ondo ; Rajesh Pahwa ; Werner Poewe ; Alexander I. Tröster ; Ryan Uitti ; Valerie Voon | Deep brain stimulation: Preoperative issues |
| 000A52 (2006) |
Anthony E. Lang ; Steven Gill ; Nik K. Patel ; Andres Lozano ; John G. Nutt ; Richard Penn ; David J. Brooks ; Gary Hotton ; Elena Moro ; Peter Heywood ; Matthew A. Brodsky ; Kim Burchiel ; Patrick Kelly ; Arif Dalvi ; Burton Scott ; Mark Stacy ; Dennis Turner ; V. G. Frederich Wooten ; William J. Elias ; Edward R. Laws ; Vijay Dhawan ; A. Jon Stoessl ; James Matcham ; Robert J. Coffey ; Michael Traub | Randomized controlled trial of intraputamenal glial cell line–derived neurotrophic factor infusion in Parkinson disease |
| 000D78 (2011) |
Kazutaka Kobayashi ; Anthony E. Lang ; Mark Hallett ; Frederick A. Lenz | Thalamic neuronal and EMG activity in psychogenic dystonia compared with organic dystonia |
| 000E28 (2013) |
Margarita Pondal ; Connie Marras ; Janis Miyasaki ; Elena Moro ; Melissa J. Armstrong ; Antonio P. Strafella ; Binit B. Shah ; Susan Fox ; L K Prashanth ; Nicolas Phielipp ; Anthony E. Lang | Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic |
| 000E55 (2010) |
Zhen Ni ; Andrew D. Pinto ; Anthony E. Lang ; Robert Chen | Involvement of the cerebellothalamocortical pathway in Parkinson disease |
| 000E60 (2009) |
C. Warren Olanow ; Jeffrey H. Kordower ; Anthony E. Lang ; Jose A. Obeso | Dopaminergic transplantation for parkinson's disease: Current status and future prospects |
| 001103 (2006) |
Susan H. Fox ; Anthony E. Lang ; Jonathan M. Brotchie | Translation of nondopaminergic treatments for levodopa‐induced dyskinesia from MPTP‐lesioned nonhuman primates to phase IIa clinical studies: Keys to success and roads to failure |
| 001165 (2008) |
Connie Marras ; Michael P. Mcdermott ; Paula A. Rochon ; Caroline M. Tanner ; Gary Naglie ; Anthony E. Lang | Predictors of deterioration in health‐related quality of life in Parkinson's disease: Results from the DATATOP trial |
| 001189 (2004) |
Katja Hedrich ; Cordula Eskelson ; Beth Wilmot ; Karen Marder ; Juliette Harris ; Jennifer Garrels ; Helen Meija-Santana ; Peter Vieregge ; Helfried Jacobs ; Susan B. Bressman ; Anthony E. Lang ; Martin Kann ; Giovanni Abbruzzese ; Paolo Martinelli ; Eberhard Schwinger ; Laurie J. Ozelius ; Peter P. Pramstaller ; Christine Klein ; Patricia Kramer | Distribution, type, and origin of Parkin mutations: Review and case studies |
| 001242 (2006) |
Claire Ardouin ; Valerie Voon ; Yulia Worbe ; Nehman Abouazar ; Virginie Czernecki ; Hassan Hosseini ; Antoine Pelissolo ; Elena Moro ; Eugénie Lhommée ; Anthony E. Lang ; Yves Agid ; Alim-Louis Benabid ; Pierre Pollak ; Luc Mallet ; Paul Krack | Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation |
| 001275 (2006) |
Olivier Rascol ; David J. Brooks ; Amos D. Korczyn ; Peter P. De Deyn ; Carl E. Clarke ; Anthony E. Lang ; Mona Abdalla | Development of dyskinesias in a 5‐year trial of ropinirole and L‐dopa |
| 001339 (2012) |
Manu Sharma ; John P A. Ioannidis ; Jan O. Aasly ; Grazia Annesi ; Alexis Brice ; Lars Bertram ; Maria Bozi ; Maria Barcikowska ; David Crosiers ; Carl E. Clarke ; Maurizio F. Facheris ; Matthew Farrer ; Gaetan Garraux ; Suzana Gispert ; Georg Auburger ; Carles Vilari O-Güell ; Georgios M. Hadjigeorgiou ; Andrew A. Hicks ; Nobutaka Hattori ; Beom S. Jeon ; Zygmunt Jamrozik ; Anna Krygowska-Wajs ; Suzanne Lesage ; Christina M. Lill ; Juei-Jueng Lin ; Timothy Lynch ; Peter Lichtner ; Anthony E. Lang ; Cecile Libioulle ; Miho Murata ; Vincent Mok ; Barbara Jasinska-Myga ; George D. Mellick ; Karen E. Morrison ; Thomas Meitnger ; Alexander Zimprich ; Grzegorz Opala ; Peter P. Pramstaller ; Irene Pichler ; Sung Sup Park ; Aldo Quattrone ; Ekaterina Rogaeva ; Owen A. Ross ; Leonidas Stefanis ; Joanne D. Stockton ; Wataru Satake ; Peter A. Silburn ; Tim M. Strom ; Jessie Theuns ; Eng- King Tan ; Tatsushi Toda ; Hiroyuki Tomiyama ; Ryan J. Uitti ; Christine Van Broeckhoven ; Karin Wirdefeldt ; Zbigniew Wszolek ; Georgia Xiromerisiou ; Harumi S. Yomono ; Kuo-Chu Yueh ; Yi Zhao ; Thomas Gasser ; Demetrius Maraganore ; Rejko Krüger | A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants |
| 001414 (2003) |
Alan L. Whone ; Ray L. Watts ; A. Jon Stoessl ; Margaret Davis ; Sven Reske ; Claude Nahmias ; Anthony E. Lang ; Olivier Rascol ; Maria J. Ribeiro ; Philippe Remy ; Werner H. Poewe ; Robert A. Hauser ; David J. Brooks | Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET study |
| 001418 (2009) |
Benedicte Ballanger ; Thilo Van Eimeren ; Elena Moro ; Andres M. Lozano ; Clement Hamani ; Philippe Boulinguez ; Giovanna Pellecchia ; Sylvain Houle ; Yu Yan Poon ; Anthony E. Lang ; Antonio P. Strafella | Stimulation of the subthalamic nucleus and impulsivity: Release your horses |
| 001511 (2011) |
Robert D. Altman ; Anthony E. Lang ; Ronald B. Postuma | Caffeine in Parkinson's disease: A pilot open‐label, dose‐escalation study |
| 001524 (2003) |
Alexandra Sailer ; Gregory F. Molnar ; Guillermo Paradiso ; Carolyn A. Gunraj ; Anthony E. Lang ; Robert Chen | Short and long latency afferent inhibition in Parkinson’s disease |
| 001544 (2011) |
Cristina Sampaio ; Juliana Bronzova ; Robert A. Hauser ; Anthony E. Lang ; Olivier Rascol ; Serge V. Van De Witte ; And Ad Theeuwes | Pardoprunox in early Parkinson's disease: Results from 2 large, randomized double‐blind trials |
| 001627 (1986) |
Ann E. Taylor ; Jean A. Saint-Cyr ; Anthony E. Lang ; Frank T. Kenny | PARKINSON'S DISEASE AND DEPRESSION |
| 001989 (2007) |
Panida Piboolnurak ; Anthony E. Lang ; Andres M. Lozano ; Janis M. Miyasaki ; Jean A. Saint-Cyr ; Yu-Yan W. Poon ; William D. Hutchison ; Jonathan O. Dostrovsky ; Elena Moro | Levodopa response in long‐term bilateral subthalamic stimulation for Parkinson's disease |
| 001A31 (2002) |
Anthony E. Lang ; Hakan Widner | Deep brain stimulation for Parkinson's disease: Patient selection and evaluation |
| 001B03 (2010) |
Anette Schrag ; Shamira Sheikh ; Niall P. Quinn ; Andrew J. Lees ; Caroline Selai ; Chris Mathias ; Irene Litvan ; Anthony E. Lang ; James H. Bower ; David J. Burn ; Philip Low ; Marjan Jahanshahi | A comparison of depression, anxiety, and health status in patients with progressive supranuclear palsy and multiple system atrophy |
| 001D51 (2010) |
Daniel Weintraub ; Mandy Sohr ; Marc N. Potenza ; Andrew D. Siderowf ; Mark Stacy ; Valerie Voon ; Jacqueline Whetteckey ; Glen R. Wunderlich ; Anthony E. Lang | Amantadine use associated with impulse control disorders in Parkinson disease in cross‐sectional study |
| 001F34 (2008) |
Shen-Yang Lim ; Michael J. Farrell ; Stephen J. Gibson ; Robert D. Helme ; Anthony E. Lang ; Andrew H. Evans | Do dyskinesia and pain share common pathophysiological mechanisms in Parkinson's disease? |
| 002280 (2010) |
Elena Moro ; Andres M. Lozano ; Pierre Pollak ; Yves Agid ; Stig Rehncrona ; Jens Volkmann ; Jaime Kulisevsky ; Jose A. Obeso ; Alberto Albanese ; Marwan I. Hariz ; Niall P. Quinn ; Jans D. Speelman ; Alim L. Benabid ; Valerie Fraix ; Alexandre Mendes ; Marie-Laure Welter ; Jean-Luc Houeto ; Philippe Cornu ; Didier Dormont ; Annalena L. Tornqvist ; Ron Ekberg ; Alfons Schnitzler ; Lars Timmermann ; Lars Wojtecki ; Andres Gironell ; Maria C. Rodriguez-Oroz ; Jorge Guridi ; Anna R. Bentivoglio ; Maria F. Contarino ; Luigi Romito ; Massimo Scerrati ; Marc Janssens ; Anthony E. Lang | Long‐term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease |
| 002902 (2007) |
Ana Djarmati ; Miodrag Gužvi ; Anne Grünewald ; Anthony E. Lang ; Peter P. Pramstaller ; David K. Simon ; Angela M. Kaindl ; Peter Vieregge ; Anders O. H. Nygren ; Christian Beetz ; Katja Hedrich ; Christine Klein | Rapid and reliable detection of exon rearrangements in various movement disorders genes by multiplex ligation‐dependent probe amplification |
| 002959 (2004) |
Anthony E. Lang ; José A. Obeso | Time to move beyond nigrostriatal dopamine deficiency in Parkinson's disease |
| 002981 (2008) |
Renato P. Munhoz ; Yosuke Wakutani ; Connie Marras ; Helio A. Teive ; Salmo Raskin ; Lineu C. Werneck ; Danielle Moreno ; Christine Sato ; Anthony E. Lang ; Ekaterina Rogaeva | The G2019S LRRK2 mutation in Brazilian patients with Parkinson's disease: Phenotype in monozygotic twins |
| 002A05 (1999) |
Glenn T. Stebbins ; Christopher G. Goetz ; Anthony E. Lang ; Esther Cubo | Factor analysis of the motor section of the unified Parkinson's disease rating scale during the off‐state |
| 002B86 (2010) |
Jerrold L. Vitek ; Kelly E. Lyons ; Roy Bakay ; Alim-Louis Benabid ; Guenther Deuschl ; Mark Hallett ; Roger Kurlan ; Joseph J. Pancrazio ; Ali Rezai ; Benjamin L. Walter ; Anthony E. Lang | Standard guidelines for publication of deep brain stimulation studies in Parkinson's disease (Guide4DBS‐PD) |
| 002C12 (2002) |
Yun J. Kim ; Masanori Ichise ; James R. Ballinger ; Douglas Vines ; Sean S. Erami ; Tatsuro Tatschida ; Anthony E. Lang | Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP |
| 002F14 (2007) |
Connie Marras ; Alexander Kopp ; Feng Qiu ; Anthony E. Lang ; Kathy Sykora ; Kenneth I. Shulman ; Paula A. Rochon | Antipsychotic use in older adults with Parkinson's disease |
